Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Langerhans Cell Histiocytoses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04469894
What this trial is testing

Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick

Who this might be right for
Niemann-Pick Diseases
National Niemann-Pick Disease Foundation 76
Not applicableUnknownNCT05137522
What this trial is testing

Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH

Who this might be right for
ChidamideHemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 20
Not applicableLooking for participantsNCT07545473
What this trial is testing

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

Who this might be right for
DementiaNeurodegenerative DiseasesAlzheimer Disease+5 more
Center for Eye Research Australia 930
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Not applicableLooking for participantsNCT03333200
What this trial is testing

Longitudinal Study of Neurodegenerative Disorders

Who this might be right for
MLDKrabbe DiseaseALD+24 more
University of Pittsburgh 1,500
Not applicableActive Not RecruitingNCT07011329
What this trial is testing

Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Hubei Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT01760564
What this trial is testing

Application of Miglustat in Patients With Niemann-Pick Type C

Who this might be right for
Niemann-Pick Disease Type C
National Taiwan University Hospital 5
Large-scale testing (Phase 3)WithdrawnNCT00488605
What this trial is testing

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

Who this might be right for
Leukemia
University of New Mexico
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableLooking for participantsNCT06197204
What this trial is testing

Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis

Who this might be right for
Histiocytosis, Langerhans-Cell
Assistance Publique - Hôpitaux de Paris 570
Not applicableStudy completedNCT03259230
What this trial is testing

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum 40
Testing effectiveness (Phase 2)Study completedNCT02385110
What this trial is testing

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00316498
What this trial is testing

Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease

Who this might be right for
Niemann Pick Diseases
National Eye Institute (NEI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05762640
What this trial is testing

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

Who this might be right for
Haemophagocytic Lymphohistiocytosis
Assistance Publique - Hôpitaux de Paris 20
Testing effectiveness (Phase 2)Study completedNCT02281760
What this trial is testing

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

Who this might be right for
BRAF V600E Mutation
National Human Genome Research Institute (NHGRI) 9
Not applicableLooking for participantsNCT07431060
What this trial is testing

Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis

Who this might be right for
Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital 120
Post-approval studies (Phase 4)UnknownNCT04999878
What this trial is testing

A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.

Who this might be right for
Hemophagocytic SyndromeT/NK-Cell Lymphoma
Zhengzhou University 30
Testing effectiveness (Phase 2)Study completedNCT06949358
What this trial is testing

Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France

Who this might be right for
Acid Sphingomyelinase Deficiency
Sanofi 3
Post-approval studies (Phase 4)UnknownNCT05284942
What this trial is testing

Central China Rosai-Dorfman Disease Registry

Who this might be right for
Rosai-Dorfman DiseaseLangerhans Cell Histiocytosis
Tongji Hospital 20
Next Page